Ran Lu

1.9k total citations
61 papers, 1.4k citations indexed

About

Ran Lu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ran Lu has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Immunology and 12 papers in Cancer Research. Recurrent topics in Ran Lu's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Cells and Metastasis (5 papers). Ran Lu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Cells and Metastasis (5 papers). Ran Lu collaborates with scholars based in China, United States and Sweden. Ran Lu's co-authors include Lunzhao Yi, Dabing Ren, Ning Chen, Xiaowei Fan, Xianming Mo, Dabing Ren, Jiamiao Liu, Pingping Gan, Yang Wang and Li Dang and has published in prestigious journals such as Nature Communications, PLoS ONE and Circulation Research.

In The Last Decade

Ran Lu

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Lu China 19 526 174 170 162 143 61 1.4k
Xiying Wu China 22 864 1.6× 198 1.1× 134 0.8× 108 0.7× 121 0.8× 57 2.1k
Ran Meng China 26 719 1.4× 176 1.0× 149 0.9× 218 1.3× 71 0.5× 67 2.4k
Wenbin Gao China 23 493 0.9× 202 1.2× 104 0.6× 167 1.0× 219 1.5× 56 1.4k
Cuiping Jiang China 21 336 0.6× 63 0.4× 139 0.8× 70 0.4× 130 0.9× 89 1.3k
Miaomiao Wang China 18 369 0.7× 61 0.4× 90 0.5× 87 0.5× 84 0.6× 69 1.1k
Jiawen Wang China 21 849 1.6× 63 0.4× 80 0.5× 112 0.7× 222 1.6× 76 2.0k
Yujiao Wang China 24 887 1.7× 137 0.8× 78 0.5× 320 2.0× 79 0.6× 98 1.7k
Lulu Zhou China 23 685 1.3× 167 1.0× 247 1.5× 171 1.1× 721 5.0× 90 2.0k
Zhenlu Li China 27 870 1.7× 118 0.7× 116 0.7× 265 1.6× 141 1.0× 76 2.2k

Countries citing papers authored by Ran Lu

Since Specialization
Citations

This map shows the geographic impact of Ran Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Lu more than expected).

Fields of papers citing papers by Ran Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Lu. The network helps show where Ran Lu may publish in the future.

Co-authorship network of co-authors of Ran Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Lu. A scholar is included among the top collaborators of Ran Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Lu. Ran Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Ran, Zheng Tang, David Julian McClements, et al.. (2025). Enhancing bioavailability and functionality of plant peptides and proteins: A review of novel strategies for food and pharmaceutical applications. Food Chemistry. 485. 144440–144440. 3 indexed citations
2.
Lu, Ran, et al.. (2025). Design, Synthesis, and Application of Immobilized Enzymes on Artificial Porous Materials. Advanced Science. 12(20). e2500345–e2500345. 9 indexed citations
3.
Geng, Shuo, Ran Lu, Yao Zhang, et al.. (2024). Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis. Circulation Research. 135(8). 856–872. 11 indexed citations
4.
Read, Kaitlin A., Michael Edwards, Ran Lu, et al.. (2024). TCDD and CH223191 Alter T Cell Balance but Fail to Induce Anti-Inflammatory Response in Adult Lupus Mice. ImmunoHorizons. 8(2). 172–181. 1 indexed citations
5.
Chen, Lijun, Shanshan Wang, Wen Zhang, et al.. (2024). Chemoproteomic Profiling Reveals Chlorogenic Acid as a Covalent Inhibitor of Arabidopsis Dehydroascorbate Reductase 1. Journal of Agricultural and Food Chemistry. 73(1). 908–918. 1 indexed citations
6.
Lu, Ran, et al.. (2024). CoS1.097 nanocrystals as new nanoplatforms for photothermal therapy of arterial inflammation. RSC Advances. 14(30). 21241–21249. 1 indexed citations
7.
Chen, Yulin, Xue Li, Qiaorong Huang, et al.. (2024). Predicting psychiatric risk: IgG N-glycosylation traits as biomarkers for mental health. Frontiers in Psychiatry. 15. 1431942–1431942. 3 indexed citations
8.
Wang, Zhuang, Rujuan Dai, Ran Lu, et al.. (2022). Phenotypic Drift in Lupus-Prone MRL/lpr Mice: Potential Roles of MicroRNAs and Gut Microbiota. ImmunoHorizons. 6(1). 36–46. 8 indexed citations
9.
Wang, Yuhang, Mengze Zhou, Ye Tao, et al.. (2022). Discovery of a Series of 5-Amide-1H-pyrazole-3-carboxyl Derivatives as Potent P2Y14R Antagonists with Anti-Inflammatory Characters. Journal of Medicinal Chemistry. 65(23). 15967–15990. 15 indexed citations
11.
Mu, Qinghui, Ran Lu, Jing Zhu, et al.. (2022). Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus-prone MRL/lpr mice. Frontiers in Immunology. 13. 923754–923754. 17 indexed citations
12.
Geng, Shuo, et al.. (2021). Resolving monocytes generated through TRAM deletion attenuate atherosclerosis. JCI Insight. 6(20). 26 indexed citations
13.
Lu, Ran, et al.. (2021). Study on the Effect and Mechanism of miR-185 on Lower Extremity Deep Venous Thrombosis. Molecular Biotechnology. 64(3). 330–337. 3 indexed citations
14.
Kumar, Dileep, Ethika Tyagi, Tong Liu, et al.. (2018). Aspirin Suppresses PGE2 and Activates AMP Kinase to Inhibit Melanoma Cell Motility, Pigmentation, and Selective Tumor Growth In Vivo. Cancer Prevention Research. 11(10). 629–642. 40 indexed citations
15.
Zhou, Xin, Chun Xiao, Yu Li, et al.. (2018). Mid1ip1b modulates apical reorientation of non-centrosomal microtubule organizing center in epithelial cells. Journal of genetics and genomics. 45(8). 433–442. 3 indexed citations
16.
Fan, Chuanwen, Xiao‐Long Chen, Ran Lu, et al.. (2017). Endothelium originated from colorectal cancer stem cells constitute cancer blood vessels. Cancer Science. 108(7). 1357–1367. 33 indexed citations
17.
Geng, Shuo, et al.. (2014). Coleusin Factor, a Novel Anticancer Diterpenoid, Inhibits Osteosarcoma Growth by Inducing Bone Morphogenetic Protein-2–Dependent Differentiation. Molecular Cancer Therapeutics. 13(6). 1431–1441. 16 indexed citations
18.
Lu, Ran. (2014). Microsatellites primer development for Ottelia acuminata(Hydrocharitaceae),a submerged macrophyte endemic to southwestern China. Guihaia. 3 indexed citations
19.
Chen, Tong, et al.. (2013). Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies. Cell Death and Disease. 4(10). e828–e828. 56 indexed citations
20.
Zhang, Shengliang, Xin Zhou, Tie Chen, et al.. (2013). Single primary fetal lung cells generate alveolar structures in vitro. In Vitro Cellular & Developmental Biology - Animal. 50(2). 87–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026